Atherosclerotic cardiovascular disease risk equivelents Clinical Trials
Conditions / Atherosclerotic cardiovascular disease risk equivelents
Delta Trials records 1 clinical trial for Atherosclerotic cardiovascular disease risk equivelents in its publicly accessible dataset. From the full dataset, 0 actively seeking eligible participants and 1 trial have reached completion. This research is conducted across 12 study locations around the world. The trial counts on this page reflect the most recent data ingested from ClinicalTrials.gov, with history tracked across multiple versions.
Trial Status
1
Total Trials
0
Recruiting
1
Completed
0
Other Active
0
Terminated since 2020
12
Study Locations
Browse by location (12 total)
- Cheadle Hulme, United Kingdom 1 trialAll trials in Cheadle Hulme, United Kingdom
- Altrincham, United Kingdom 1 trialAll trials in Altrincham, United Kingdom
- Swinton, United Kingdom 1 trialAll trials in Swinton, United Kingdom
- All trials in Greater Manchester, United Kingdom
- Manchester, United Kingdom 1 trialAll trials in Manchester, United Kingdom
- Wythenshawe, United Kingdom 1 trialAll trials in Wythenshawe, United Kingdom
- Didsbury, United Kingdom 1 trialAll trials in Didsbury, United Kingdom
- Northenden, United Kingdom 1 trialAll trials in Northenden, United Kingdom
- Lancashire, United Kingdom 1 trialAll trials in Lancashire, United Kingdom
- Sale, United Kingdom 1 trialAll trials in Sale, United Kingdom
- Davyhulme, United Kingdom 1 trialAll trials in Davyhulme, United Kingdom
- Chadderton, United Kingdom 1 trialAll trials in Chadderton, United Kingdom